Not applicableUnknownNCT04563650What this trial is testingCOVID-19 Serology and ImmunosenescenceWho this might be right forCovid19Geriatric MedicineSeroconversion+1 more Centre Hospitalier Universitaire, Amiens 98
Testing effectiveness (Phase 2)Study completedNCT00924170What this trial is testingPhase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell LeukemiaWho this might be right forAdult T-Cell Leukemia (ATL) National Cancer Institute (NCI) 18
Not applicableUnknownNCT05274373What this trial is testingClinical, Virological, Serological and Immunological Characteristics During and Following COVID-19 HospitalizationWho this might be right forCOVID-19 PneumoniaCOVID-19 Nordsjaellands Hospital 47
Not applicableUnknownNCT05484700What this trial is testingAntibodies and Immunity After Vaccination of Recovered Patients With COVID-19 and Long COVID-19 SymptomsWho this might be right forLong COVID-19 Mahidol University 305
Not applicableUnknownNCT05827939What this trial is testingAssociation of Phenotypic Age and Antibody Titers Among SARS-Co-V2 Infected Patients and Vaccinated GroupsWho this might be right forCOVID-19 Chang Gung Memorial Hospital 330
Early research (Phase 1)UnknownNCT00062530What this trial is testingSafety of an Oral HIV Vaccine in HIV Uninfected VolunteersWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 38
Testing effectiveness (Phase 2)Study completedNCT03721510What this trial is testingA Phase 1/2a Study of PGT121, VRC07-523LS and PGDM1400 Monoclonal Antibodies in HIV-uninfected and HIV-infected AdultsWho this might be right forHIV/AIDS International AIDS Vaccine Initiative 19
Testing effectiveness (Phase 2)Study completedNCT01426789What this trial is testingA Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) PatientsWho this might be right forRheumatoid Arthritis Novartis Pharmaceuticals 100
Early research (Phase 1)Study completedNCT03015181What this trial is testingVRC 605: Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered Intravenously or Subcutaneously to Healthy AdultsWho this might be right forHIV Prevention National Institute of Allergy and Infectious Diseases (NIAID) 26
Testing effectiveness (Phase 2)Study completedNCT02716675What this trial is testingEvaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With MenWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 2,699
Post-approval studies (Phase 4)Study completedNCT02991872What this trial is testingEvaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese ChildrenWho this might be right forVirus Diseases GlaxoSmithKline 150
Not applicableNot Yet RecruitingNCT06988072What this trial is testingStudy of Anti-BKPyV Immune Responses in Kidney Transplant Patients With BKPyV ViremiaWho this might be right forBK PolyomavirusKidney Transplant Assistance Publique - Hôpitaux de Paris 75
Not applicableStudy completedNCT04844489What this trial is testingStudy of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised PeopleWho this might be right forAutoimmune or Autoinflammatory DiseasesHIVMultiple Sclerosis+2 more Assistance Publique - Hôpitaux de Paris 377
Not applicableStudy completedNCT00336557What this trial is testingDetermine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN TherapyWho this might be right forMultiple Sclerosis Teva Branded Pharmaceutical Products R&D, Inc. 1,230
Testing effectiveness (Phase 2)Study completedNCT05625477What this trial is testingStudy to Compare the Anti-tetanus Neutralizing Antibody Titers and Safety of TNM002 Injection With Human Tetanus Immunoglobulin or Placebo in Adult VolunteersWho this might be right forTetanus Zhuhai Trinomab Pharmaceutical Co., Ltd. 240
Testing effectiveness (Phase 2)Study completedNCT02588586What this trial is testingThe Safety and Antiretroviral Activity of 3BNC117Who this might be right forHIV-1 Infection Rockefeller University 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT05729568What this trial is testingTeropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 InfectionWho this might be right forHIV-1 Infection Gilead Sciences 83
Early research (Phase 1)Study completedNCT04532294What this trial is testingSafety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy ParticipantsWho this might be right forCovid19 BeiGene 18
Not applicableUnknownNCT04679428What this trial is testingImmunological Characteristics of COVID-19 PatientsWho this might be right forCovid19 The University Clinic of Pulmonary and Allergic Diseases Golnik 230
Testing effectiveness (Phase 2)UnknownNCT06042764What this trial is testingSA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 PatientsWho this might be right forInfection of Upper Respiratory Tract Caused by 2019-nCoV Sinovac Life Sciences Co., Ltd. 150